Lifecore Biomedical, Inc. De (LFCR) Restructuring Costs (2020 - 2025)

Lifecore Biomedical's Restructuring Costs history runs 6 years deep, the most recent figure standing at -$2.5 million for Q2 2025.

• In Q2 2025, Restructuring Costs fell 441.33% year-over-year to -$2.5 million; the TTM figure through May 2025 stood at -$1.1 million (down 167.93% YoY), while the FY2025 annual figure was -$1.7 million, down 205.5% from the prior year.
• Restructuring Costs was -$2.5 million for Q2 2025 at Lifecore Biomedical, down from -$115000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $13.4 million in Q2 2021 to a low of -$2.5 million in Q2 2025.
• Historically, Restructuring Costs has averaged $1.7 million across 5 years, with a median of $754500.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs surged 9125.0% in 2024, then tumbled 441.33% in 2025.
• A 5-year view of Restructuring Costs shows it stood at $627000.0 in 2021, then retreated by 10.21% to $563000.0 in 2022, then tumbled by 72.11% to $157000.0 in 2023, then surged by 370.06% to $738000.0 in 2024, then sank by 441.33% to -$2.5 million in 2025.
• The last three Restructuring Costs figures came in at -$2.5 million (Q2 2025), -$115000.0 (Q1 2025), and $738000.0 (Q2 2024), per Business Quant data.